Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

Gut. 2010 May;59(5):666-89. doi: 10.1136/gut.2009.179804.

Abstract

The British Society of Gastroenterology (BSG) and the Association of Coloproctology for Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The aim, as before, is to provide guidance on the appropriateness, method and frequency of screening for people at moderate and high risk from colorectal cancer. This guidance provides some new recommendations for those with inflammatory bowel disease and for those at moderate risk resulting from a family history of colorectal cancer. In other areas guidance is relatively unchanged, but the recent literature was reviewed and is included where appropriate.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Acromegaly / complications
  • Adenoma / diagnosis
  • Anastomosis, Surgical / adverse effects
  • Colon, Sigmoid / surgery
  • Colonoscopy / methods
  • Colonoscopy / standards
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / etiology
  • Colorectal Neoplasms / surgery
  • Early Detection of Cancer / methods*
  • Early Detection of Cancer / standards
  • Evidence-Based Medicine / methods
  • Humans
  • Inflammatory Bowel Diseases / complications
  • Neoplastic Syndromes, Hereditary / diagnosis
  • Population Surveillance / methods
  • State Medicine / standards
  • Ureter / surgery